TABLE OF CONTENTS
|  | | | Volume 109, Issue 10 (2507-2762)
Published online 12 November 2013
|  | In this issue
 Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics and Genomics
Also new today
 Advance online publication
| | | | | | Advertisement | | | | | | Clinical Studies | Top | | Is it possible to improve the breaking bad news skills of residents when a relative is present? A randomised study I Merckaert, A Liénard, Y Libert, I Bragard, N Delvaux, A-M Etienne, S Marchal, J Meunier, C Reynaert, J-L Slachmuylder and D Razavi Br J Cancer 2013 109: 2507-2514; advance online publication, October 15, 2013; 10.1038/bjc.2013.615 Abstract | Full Text | | | | Validation of the Children’s International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCT S Jacobs, C Baggott, R Agarwal, T Hesser, T Schechter, P Judd, D Tomlinson, J Beyene and L Sung Br J Cancer 2013 109: 2515-2522; advance online publication, October 15, 2013; 10.1038/bjc.2013.618 Abstract | Full Text | | | | Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment U Thiel, E Koscielniak, F Blaeschke, T G P Grunewald, M Badoglio, M A Diaz, C Paillard, A Prete, M Ussowicz, P Lang, F Fagioli, P Lutz, G Ehninger, P Schneider, A Santucci, P Bader, B Gruhn, M Faraci, P Antunovic, J Styczynski, W H Krüger, L Castagna, P Rohrlich, M Ouachée-Chardin, A Salmon, C Peters, M Bregni, S Burdach and On behalf of the Solid Tumour Working Party and the Paediatric Disease Working Party of the European Group for Blood and Marrow Transplantation Br J Cancer 2013 109: 2523-2532; advance online publication, October 22, 2013; 10.1038/bjc.2013.630 Abstract | Full Text | | | | Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer A J Sutton, P Barton, S Sundar, C Meads, A N Rosenthal, P Baldwin, K Khan and T E Roberts Br J Cancer 2013 109: 2533-2547; advance online publication, October 15, 2013; 10.1038/bjc.2013.631 Abstract | Full Text | | | | The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine L C Harshman, R Fougeray, T K Choueiri, F A Schutz, Y Salhi, J E Rosenberg and J Bellmunt Br J Cancer 2013 109: 2548-2553; advance online publication, October 15, 2013; 10.1038/bjc.2013.617 Abstract | Full Text | | | | Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001) S Nicholson, E Hall, S J Harland, J D Chester, L Pickering, J Barber, T Elliott, A Thomson, S Burnett, C Cruickshank, B Carrington, R Waters and A Bahl Br J Cancer 2013 109: 2554-2559; advance online publication, October 29, 2013; 10.1038/bjc.2013.620 Abstract | Full Text | | | | A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity A Gibb, A Greystoke, M Ranson, K Linton, S Neeson, G Hampson, T Illidge, E Smith, C Dive, A Pettitt, A Lister, P Johnson and J Radford Br J Cancer 2013 109: 2560-2565; advance online publication, October 17, 2013; 10.1038/bjc.2013.605 Abstract | Full Text | | | | Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma T Illidge, C Chan, N Counsell, S Morris, J Scarisbrick, D Gilson, B Popova, P Patrick, P Smith, S Whittaker and R Cowan Br J Cancer 2013 109: 2566-2573; advance online publication, October 17, 2013; 10.1038/bjc.2013.616 Abstract | Full Text | | | | A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours A Adenis, I Ray-Coquard, A Italiano, E Chauzit, B Bui-Nguyen, J-Y Blay, E Tresch-Bruneel, C Fournier, S Clisant, E Y Amela, P A Cassier, M Molimard and N Penel Br J Cancer 2013 109: 2574-2578; advance online publication, October 22, 2013; 10.1038/bjc.2013.648 Abstract | Full Text | | | | First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer D Bianchini, A Omlin, C Pezaro, D Lorente, R Ferraldeschi, D Mukherji, M Crespo, I Figueiredo, S Miranda, R Riisnaes, A Zivi, A Buchbinder, D E Rathkopf, G Attard, H I Scher, J de Bono and D C Danila Br J Cancer 2013 109: 2579-2586; advance online publication, October 29, 2013; 10.1038/bjc.2013.619 Abstract | Full Text | | Translational Therapeutics | Top | | Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells S Suman, T P Das and C Damodaran Br J Cancer 2013 109: 2587-2596; advance online publication, October 15, 2013; 10.1038/bjc.2013.642 Abstract | Full Text | | | | Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours E Seront, R Boidot, C Bouzin, O Karroum, B F Jordan, B Gallez, J-P Machiels and O Feron Br J Cancer 2013 109: 2597-2606; advance online publication, October 24, 2013; 10.1038/bjc.2013.644 Abstract | Full Text | | | | Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma E Tavanti, V Sero, S Vella, M Fanelli, F Michelacci, L Landuzzi, G Magagnoli, R Versteeg, P Picci, C M Hattinger and M Serra Br J Cancer 2013 109: 2607-2618; advance online publication, October 15, 2013; 10.1038/bjc.2013.643 Abstract | Full Text | | | | A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma M Yashiro, T Nishii, T Hasegawa, T Matsuzaki, T Morisaki, T Fukuoka and K Hirakawa Br J Cancer 2013 109: 2619-2628; advance online publication, October 15, 2013; 10.1038/bjc.2013.638 Abstract | Full Text | | Molecular Diagnostics | Top | | Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients H-B Jie, N Gildener-Leapman, J Li, R M Srivastava, S P Gibson, T L Whiteside and R L Ferris Br J Cancer 2013 109: 2629-2635; advance online publication, October 29, 2013; 10.1038/bjc.2013.645 Abstract | Full Text | | | | Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma T Kinoshita, N Nohata, T Hanazawa, N Kikkawa, N Yamamoto, H Yoshino, T Itesako, H Enokida, M Nakagawa, Y Okamoto and N Seki Br J Cancer 2013 109: 2636-2645; advance online publication, October 3, 2013; 10.1038/bjc.2013.607 Abstract | Full Text | | | | MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis R M Silva-Santos, P Costa-Pinheiro, A Luis, L Antunes, F Lobo, J Oliveira, R Henrique and C Jerónimo Br J Cancer 2013 109: 2646-2653; advance online publication, October 15, 2013; 10.1038/bjc.2013.552 Abstract | Full Text | | | | Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value M Evert, M Frau, M L Tomasi, G Latte, M M Simile, M A Seddaiu, A Zimmermann, S Ladu, T Staniscia, S Brozzetti, G Solinas, F Dombrowski, F Feo, R M Pascale and D F Calvisi Br J Cancer 2013 109: 2654-2664; advance online publication, October 17, 2013; 10.1038/bjc.2013.606 Abstract | Full Text | | | | Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer B Goeppert, L Frauenschuh, M Zucknick, A Stenzinger, M Andrulis, F Klauschen, K Joehrens, A Warth, M Renner, A Mehrabi, M Hafezi, A Thelen, P Schirmacher and W Weichert Br J Cancer 2013 109: 2665-2674; advance online publication, October 17, 2013; 10.1038/bjc.2013.610 Abstract | Full Text | | | | SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1 H Zhang, Y Xu, A Filipovic, L C Lit, C-Y Koo, J Stebbing and G Giamas Br J Cancer 2013 109: 2675-2684; advance online publication, October 15, 2013; 10.1038/bjc.2013.628 Abstract | Full Text | | | | Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL A Meijer, F A E Kruyt, A G J van der Zee, H Hollema, P Le, K A ten Hoor, G M M Groothuis, W J Quax, E G E de Vries and S de Jong Br J Cancer 2013 109: 2685-2695; advance online publication, October 17, 2013; 10.1038/bjc.2013.636 Abstract | Full Text | | | | Variability in functional p53 reactivation by PRIMA-1Met/APR-246 in Ewing sarcoma D N T Aryee, S Niedan, J Ban, R Schwentner, K Muehlbacher, M Kauer, R Kofler and H Kovar Br J Cancer 2013 109: 2696-2704; advance online publication, October 15, 2013; 10.1038/bjc.2013.635 Abstract | Full Text | | | | Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer A N Seo, H J Lee, E J Kim, H J Kim, M H Jang, H E Lee, Y J Kim, J H Kim and S Y Park Br J Cancer 2013 109: 2705-2713; advance online publication, October 15, 2013; 10.1038/bjc.2013.634 Abstract | Full Text | | | | MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion N Falkenberg, N Anastasov, K Rappl, H Braselmann, G Auer, A Walch, M Huber, I Höfig, M Schmitt, H Höfler, M J Atkinson and M Aubele Br J Cancer 2013 109: 2714-2723; advance online publication, October 15, 2013; 10.1038/bjc.2013.625 Abstract | Full Text | | Genetics and Genomics | Top | | MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours M Tanic, E Andrés, S M Rodriguez-Pinilla, I Marquez-Rodas, M Cebollero-Presmanes, V Fernandez, A Osorio, J Benítez and B Martinez-Delgado Br J Cancer 2013 109: 2724-2734; advance online publication, October 8, 2013; 10.1038/bjc.2013.612 Abstract | Full Text | | | | ALK gene amplification is associated with poor prognosis in colorectal carcinoma P Bavi, Z Jehan, R Bu, S Prabhakaran, N Al-Sanea, F Al-Dayel, M Al-Assiri, T Al-Halouly, R Sairafi, S Uddin and K S Al-Kuraya Br J Cancer 2013 109: 2735-2743; advance online publication, October 15, 2013; 10.1038/bjc.2013.641 Abstract | Full Text | | | | DICER1 hotspot mutations in non-epithelial gonadal tumours L Witkowski, J Mattina, S Schönberger, M J Murray, D G Huntsman, J S Reis-Filho, W G McCluggage, J C Nicholson, N Coleman, G Calaminus, D T Schneider, J Arseneau, C J R Stewart and W D Foulkes Br J Cancer 2013 109: 2744-2750; advance online publication, October 17, 2013; 10.1038/bjc.2013.637 Abstract | Full Text | | | | Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex B Giessrigl, W M Schmidt, M Kalipciyan, M Jeitler, M Bilban, M Gollinger, S Krieger, W Jäger, R M Mader and G Krupitza Br J Cancer 2013 109: 2751-2762; advance online publication, October 29, 2013; 10.1038/bjc.2013.583 Abstract | Full Text | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
| |
No comments:
Post a Comment